Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simple header and a Home link, indicating restricted access rather than active content. The previously visible study details have been removed, leaving an error state.
    Difference
    19%
    Check dated 2026-09-24T18:07:24.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added and Revision: v3.6.6 was removed, indicating a new page version in the site's revision history. This update does not alter page content or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-17T18:53:43.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a background update to the site or content-management system.
    Difference
    0.0%
    Check dated 2026-09-03T18:21:18.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    An NIH grant/contract line for 2019 was added, and a new publication citation (Regnault et al., 2024) regarding tolerability in LIBRETTO-531 was also added.
    Difference
    0.0%
    Check dated 2026-08-27T15:50:48.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 was added and the previous Revision: v3.6.4 was removed, indicating a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-08-13T11:39:17.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a small frontend update to the study details page. This change does not modify study content or data.
    Difference
    0.0%
    Check dated 2026-07-23T08:37:38.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.